EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Comparative Efficacy and Safety of Low‐Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis

Ahmed Ibrahim, Laila Shalabi iD, Sofian Zreigh iD, Shrouk Ramadan, Sohaila Mourad, Ghaith Eljadid iD, Mohammed Beshr, Ali Abdelaziz iD, Muhammed Elhadi iD, Pierre Sabouret iD, Mamas Mamas iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31461 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Ahmed Ibrahim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Platelet Aggregation Inhibitors, Dual Anti-Platelet Therapy. Die Arbeit nennt 50 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left atrial appendage occlusion (LAAO) is an alternative to chronic oral anticoagulation (OAT) for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients with contraindications to OAT. Postprocedure antithrombotic therapy (ATT) is essential to reduce the risk of device‐related thrombosis (DRT), but the optimal regimen remains uncertain.

Aims

This study aims to compare the safety and efficacy of low‐dose direct oral anticoagulants (DOACs) versus dual antiplatelet therapy (DAPT) following LAAO.

Methods

A comprehensive search of PubMed, Scopus, Cochrane, and Web of Science was conducted in August 2024. Studies comparing low‐dose DOACs and DAPT post‐LAAO were included. The primary outcomes were a composite efficacy endpoint (DRT, strokes, and systemic embolism [SE]) and major bleeding events as the safety endpoint. Secondary outcomes included all bleeding events, all‐cause mortality, and a composite of efficacy and safety endpoints.

Results

Four studies with 727 patients were included. Low‐dose DOACs were associated with lower rates of the primary composite efficacy endpoint compared to DAPT (OR = 0.36; 95% CI [0.16, 0.85], p = 0.01). No significant difference in major bleeding events was observed (OR = 0.36; 95% CI [0.11, 1.18]; p = 0.091; I ² = 0%). Compared to DAPT, low‐dose DOACs were also associated with lower rates of DRT events (OR = 0.36; 95% CI [0.16, 0.79], p = 0.011).

Conclusion

Low‐dose DOACs effectively reduce thromboembolic events post‐LAAO without increasing bleeding risk. These findings support their use as a viable ATT option, but larger trials are needed to confirm optimal regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial AppendagePlatelet Aggregation InhibitorsDual Anti-Platelet TherapyStrokeFactor Xa InhibitorsAnticoagulantsHumansTreatment OutcomeAdministration, OralRisk FactorsHemorrhageRisk AssessmentAgedMaleFemaleMiddle AgedAged, 80 and overTime Factors

Stichwörter der Autor:innen

device‐related thrombosisdual antiplatelet therapyleft atrial appendage occlusionlow‐dose direct oral anticoagulantnonvalvular atrial fibrillation

Substanzen

Platelet Aggregation InhibitorsFactor Xa InhibitorsAnticoagulants

Autor:innen und Institutionen

  • Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Faculty of Medicine, Gharyan University, Gharyan, Libya.
  • Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
  • Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
  • Korea University College of Medicine, Seongbuk-gu, Seoul, Republic of Korea.

ORCID-Profile: Laila Shalabi, Sofian Zreigh, Ghaith Eljadid, Ali Abdelaziz, Muhammed Elhadi, Pierre Sabouret, Mamas Mamas

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Ibrahim, A., Shalabi, L., Zreigh, S., Ramadan, S., Mourad, S., Eljadid, G., Beshr, M., Abdelaziz, A., Elhadi, M., Sabouret, P., & Mamas, M. (2025). Comparative Efficacy and Safety of Low‐Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31461

Vancouver

Ibrahim A, Shalabi L, Zreigh S, Ramadan S, Mourad S, Eljadid G, et al. Comparative Efficacy and Safety of Low‐Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31461

BibTeX
@article{Ibrahim2025,
  author = {Ibrahim, Ahmed and Shalabi, Laila and Zreigh, Sofian and Ramadan, Shrouk and Mourad, Sohaila and Eljadid, Ghaith and Beshr, Mohammed and Abdelaziz, Ali and Elhadi, Muhammed and Sabouret, Pierre and Mamas, Mamas},
  title = {Comparative Efficacy and Safety of Low‐Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31461}
}
Kostenlos starten →